Prothena | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
ALKERMES USD 1.64B 156.24M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amgen USD 26.73B 195M 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Exelixis USD 1.18B 215.74M 2025-07
Incyte USD 3.64B 411.91M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
MacroGenics USD 217.49M 4.71M 2024-12
Neurocrine Biosciences USD 1.75B 111M 2025-06
Prothena USD 485.41M 49.57M 2024-12
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Prothena Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.